Citigroup Inc Amgen Inc Put Options Transaction History

Citigroup Inc

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $7.58 Million - $8.27 Million	24,500 Added 54.44%	69,500 $22.4 Million
Q2 2024 Aug 12, 2024	BUY	$262.75 - $319.31 $11.8 Million - $14.4 Million	45,000 New	45,000 $14.1 Million
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $5.38 Million - $6.36 Million	-25,100 Reduced 67.65%	12,000 $2.66 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $29.9 Million - $36.5 Million	-132,500 Reduced 78.13%	37,100 $8.97 Million
Q4 2022 Feb 09, 2023	BUY	$229.03 - $291.01 $2.77 Million - $3.52 Million	12,100 Added 7.68%	169,600 $44.5 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $17.5 Million - $19.7 Million	-78,000 Reduced 33.12%	157,500 $35.5 Million
Q2 2022 Aug 10, 2022	SELL	$230.71 - $256.74 $70.8 Million - $78.8 Million	-307,000 Reduced 56.59%	235,500 $57.3 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $28.1 Million - $31.1 Million	128,300 Added 30.98%	542,500 $131 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $27.6 Million - $31.6 Million	138,800 Added 50.4%	414,200 $93.2 Million
Q3 2021 Nov 10, 2021	BUY	$212.27 - $248.7 $58.5 Million - $68.5 Million	275,400 New	275,400 $58.6 Million

3,125

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.